|

Verekitug Clinical Trials

2 actively recruiting trials across 1 location

Also known as: UPB-101

Pipeline

Phase 2: 2

Top Sponsors

  • Upstream Bio Inc.2

Indications

  • Severe Asthma1
  • Chronic Obstructive Pulmonary Disease1
  • Asthma1
  • COPD1

Bakersfield, California2 trials

A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)

Kern Research, Inc.

Phase 2
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD

Kern Research Inc.

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.